Focus topic: | Life Science Technologies |
---|---|
Type of funding: | Individual funding programmes |
Programme: | CZS Nexus |
Funded institution: |
|
Dr. Gözde Kabay researches various biomedical fields including biosensors, biomaterials, theranostics and plasma technologies. She studied biomedical engineering in Turkey. After stations in Madison (USA) and Freiburg, she has been a postdoctoral researcher at KIT since 2021.
Goals
Acute kidney injury (AKI) refers to a sudden and reversible reduction in kidney function that leads to an accumulation of waste products in the body. If not diagnosed in time, it can lead to irreversible damage.
Currently, existing formal diagnostic parameters are inadequate in terms of specificity and sensitivity, and tests and equipment used to examine patient samples are cumbersome and costly. Therefore, portable and low-cost biosensors are being developed to enable simultaneous and sensitive detection of early-stage AKI biomarkers to improve AKI prognosis and patient:outcomes.
Dr. Kabay's multidisciplinary team is focused on developing such a low-cost, accessible and user-friendly AKI biosensor to detect multiple AKI-related biomarkers in a timely and simultaneous manner with high performance.
Involved persons:
Dr. Gözde Kabay
Karlsruher Institut für Technologie
Detailed information:
Focus topic: | Life Science Technologies |
---|---|
Programme: | CZS Nexus |
Type of funding: | Individual funding programmes |
Target group: | Junior research group leaders |
---|---|
Funding budget: | 1.499.000 € |
Period of time: | Oktober 2023 - September 2028 |